C4 Therapeutics CCCC
NASDAQ CCCC
$2.89 -0.11 (-3.67%)
At close: Nov 11, 2026 · 4:00 PM EST

C4 Therapeutics (CCCC) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

C4 Therapeutics' Return on Capital Employed [ROCE] was -37.77% in Q2 2026, up 9.13 percentage points from -46.90% a year earlier but down 1.83 percentage points from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at C4 Therapeutics came in at -35.86%, up 1.77 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of -7.79 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -37.63% in FY2024 (+0.89 pp), -38.53% in FY2023 (-7.99 pp), -30.53% in FY2022 (-10.11 pp) and -20.42% in FY2021 (+7.65 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -52.96% (Q3 2025) and -18.01% (Q4 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of -0.51 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 9.13 percentage points); the worst was Q2 2023 (a drop of 21.40 percentage points).
  • Per Business Quant data, CCCC's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -35.94% (Q1 2026), -41.26% (Q4 2025) and -52.96% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 C4 Therapeutics 393.93 Mn -549.34 Mn - -33.52%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -33.52%
Jun 30, 2026 -37.77%
Mar 31, 2026 -35.94%
Dec 31, 2025 -41.26%
Sep 30, 2025 -52.96%
Jun 30, 2025 -46.90%
Mar 31, 2025 -39.68%
Dec 31, 2024 -37.66%
Sep 30, 2024 -35.59%
Jun 30, 2024 -35.44%
Mar 31, 2024 -40.62%
Dec 31, 2023 -44.57%
Sep 30, 2023 -43.21%
Jun 30, 2023 -42.87%
Mar 31, 2023 -35.93%
Dec 31, 2022 -32.26%
Sep 30, 2022 -24.67%
Jun 30, 2022 -21.46%
Mar 31, 2022 -20.04%
Dec 31, 2021 -18.01%
API Access

C4 Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CCCC&period=max&api_key=YOUR_API_KEY